Direct oral anticoagulants (DOACs) are attractive options for treatment of heparin-induced
thrombocytopenia (HIT). We report our continuing experience in Hamilton, ON, Canada …

Heparin-induced thrombocytopenia (HIT) is associated with clinically significant morbidity
and mortality. Patients who are critically ill are commonly thrombocytopenic and exposed to …

Heparin-Induced Thrombocytopenia (HIT) is a rare, iatrogenic disease characterised by its
potential severity, mainly related to thrombosis, and by difficulties regarding its diagnosis …

Background The effectiveness and safety of non‐heparin anticoagulants for the treatment of
heparin‐induced thrombocytopenia (HIT) are not fully established, and the optimal treatment …

Heparin‐induced thrombocytopenia (HIT) is a rare, potentially life‐threatening condition
secondary to unfractionated heparin or low molecular weight heparin exposure. This …

Background Heparin-induced thrombocytopenia (HIT) is a relatively uncommon condition
characterized by two exceedingly common phenomena in hospitalized patients …

BACKGROUND The ADAMTS13 test distinguishes thrombotic thrombocytopenic purpura
(TTP) from other thrombotic microangiopathies (TMAs). The PLASMIC score helps …

Objective: To explore and analyze the efficacy and safety of combined treatment of
Agatroban and Aspirin in improving short-term and long-term prognosis of ischemic stroke …

Background: In this study, we investigate the incidence of venous thrombosis (VT), and
evaluate the effectiveness and safety of 3 major thromboprophylaxes and the potential risk …

Heparin-induced thrombocytopenia (HIT) and heparin-induced thrombocytopenia with
thrombosis (HITT) are rare but potentially limb-and life-threatening complications of heparin …